在FDA不良事件报告系统 (FAERS) 数据库中对托波特干的真实数据分析
Haiyan Yang1, Zheng Wan2, Moliang Chen3,4
1Department of Gynecological Oncology, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China.
Expert opinion on drug metabolism & toxicology
|May 27, 2023
概括
这项研究监测了癌症药物托波特干的不良事件 (AEs). 确定了意想不到的眼睛疾病风险,提高了患者的安全性和指导药物使用.
科学领域:
- 药物监督 药物监督 药物监督
- 在瘤学瘤学.
- 药品安全 药品安全
背景情况:
- 托波特坎是固体瘤的关键治疗方法.
- 监测不良事件 (AE) 对患者安全至关重要.
- 现实世界的数据分析有助于识别与毒品相关的风险.
研究的目的:
- 监测和识别与topotecan相关的不良事件 (AE).
- 为了提高患者的安全性和指导托波特坎药物使用.
- 通过使用现实世界的数据来评估托波特坎相关的副作用的不成比例性.
主要方法:
- 使用了四个算法 (ROR,PRR,BCPNN,EBGM) 来检测AE信号.
- 分析了来自FAERS数据库的9511.161份病例报告 (2004Q1-2021Q4).
- 专注于1896个主要可疑的 (PS) 副作用和155个与托波特干相关的药物不良反应 (ADRs) 在23个器官系统的首选术语 (PTs) 层面.
主要成果:
- 确定了预期的不良反应,如贫血,恶心和吐,与药物标签一致.
- 在系统器官类 (SOC) 级别的眼睛疾病中发现了意想不到的显著的副作用.
- 确认了1,896个首要可疑的副作用和155个与托波特坎相关的副作用.
结论:
- 确定了与托波特坎相关的新的,意想不到的不良药物反应 (ADRs).
- 研究结果提供了对托波特坎相关的不良反应有价值的见解.
- 强调持续药物监测对托波特干安全性的重要性.
相关概念视频
01:19Pharmacovigilance
916
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
916
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:11Clinical Trials: Overview
3.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
150
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
150
01:16Clinical Trials
6.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.9K
01:07Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K